January 3, 2018
Boehringer Ingelheim doubles funding to 250 M€ for its corporate venture fund
Boehringer Ingelheim today announced an increase in funding for its corporate venture fund, known as the Boehringer Ingelheim Venture Fund (BIVF), from EUR 100 to 250 million.